Lead-like, drug-like or "Pub-like": how different are they? - Tudor I. Oprea; Tharun Kumar Allu; Dan C. Fara; Ramona F. Rad; Liliana Ostopovici; Cristian Bologa (J. Comput. Aided Mol. Des., 2007)

Modeling Kinase Inhibition Using Highly Confident Data Sets. - Sorin I. Avram; Alina Bora; Liliana Halip; Ramona Curpan (J. Chem. Inf. Model., 2018)

Off-Patent Drug Repositioning. - Sorin I. Avram; Ramona Curpan; Liliana Halip; Alina Bora; Tudor I. Oprea (J. Chem. Inf. Model., 2020)

DrugCentral 2021 supports drug discovery and repositioning. - Sorin I. Avram; Cristian Bologa; Jayme Holmes; Giovanni Bocci; Thomas B. Wilson; Dac-Trung Nguyen; Ramona Curpan; Liliana Halip; Alina Bora; Jeremy J. Yang; Jeffrey Knockel; Suman Sirimulla; et al. (Nucleic Acids Res., 2021)

DrugCentral 2023 extends human clinical data and integrates veterinary drugs. - Sorin I. Avram; Thomas B. Wilson; Ramona Curpan; Liliana Halip; Ana Borota; Alina Bora; Cristian Bologa; Jayme Holmes; Jeffrey Knockel; Jeremy J. Yang; Tudor I. Oprea (Nucleic Acids Res., 2023)

Exploring DrugCentral: from molecular structures to clinical effects. - Liliana Halip; Sorin I. Avram; Ramona Curpan; Ana Borota; Alina Bora; Cristian Bologa; Tudor I. Oprea (J. Comput. Aided Mol. Des., 2023)

Correction: Exploring DrugCentral: from molecular structures to clinical effects. - Liliana Halip; Sorin I. Avram; Ramona Curpan; Ana Borota; Alina Bora; Cristian Bologa; Tudor I. Oprea (J. Comput. Aided Mol. Des., 2024)